placeholder image
J. S. Wefel All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Dual immune check point blockade in MGMT-unmethylated newly diagnosed glioblastoma: NRG Oncology BN007, a randomized phase II/III clinical trial. 
    Journal of Clinical Oncology. 2025
  • Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial. 
    Neuro-Oncology. 2023
  • Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 
    Neurooncol Adv. 2023
    • Contact
    full name
  • J. S. Wefel
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration